about
HBV induced HCC: major risk factors from genetic to molecular levelOccult hepatitis B virus infectionAndrogen receptor signaling in hepatocellular carcinoma and pancreatic cancersHepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedCirculating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsCharacterization of a Novel Hepadnavirus in the White Sucker (Catostomus commersonii) from the Great Lakes Region of the United StatesViral hepatitis and hepatocellular carcinoma: etiology and managementOccult hepatitis B virus and hepatocellular carcinomaChronic inflammation and cytokines in the tumor microenvironment.Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cellsMethylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatmentViral carcinogenesis: factors inducing DNA damage and virus integrationSoluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control studyRelative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.Establishment of drug-resistant HBV small-animal models by hydrodynamic injectionTransposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.Differential Expression of Wnt Pathway Genes in Sporadic Hepatocellular Carcinomas Infected With Hepatitis B Virus Identified With OligoGE Arrays.Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patientsLiver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.Th17 cells and their associated cytokines in liver diseases.Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral statusExogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells.Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B.IFN- alpha blocks IL-17 production by peripheral blood mononuclear cells in patients with chronic active hepatitis B Infection.Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B.Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.
P2860
Q26825274-48925447-843E-4DA8-9730-1BDBF733EE5FQ27004224-C2AFB8DC-A635-44CD-9CAA-E2765FA3DCEFQ27004276-8EBC4814-5AA0-4D91-82D5-E3F74E6DF2B6Q28076703-5299BC98-242E-42CB-A189-54B3488A169CQ28080175-37BD68FA-3D29-4CE9-B8F4-EE742E8A6ECCQ28383646-7927644A-413B-483B-A707-898D64E16869Q28607462-D2835EE7-D711-42E2-8C22-8C9A1D35DDFAQ33593219-E81E8615-0FB9-4794-8FB8-55FEBAC5CF3BQ33661018-19659006-26B3-4043-94FE-78A036835CD4Q33678275-E491450A-2EEC-4851-9DE9-77D3DD7EAA6AQ33833475-CECC97F7-7A3E-41C5-98A8-6ACCF13344DAQ34004837-C4563E06-93DA-4ACF-9098-7D4A367B0013Q34685836-FECDCB3F-FE86-4F1E-9860-B36527290806Q34774880-94D5C704-23B2-421A-B0FE-E1E6FBCC5239Q35053561-85770AC2-C1DE-42D7-BECD-30E2C752E001Q35567341-839201E0-4C59-47D3-9D36-8649B8B4B561Q35750064-AFC0CC53-A3AA-4521-A74B-DCB63982A112Q35751930-24267A2E-42B4-4343-9635-B5074026D633Q35828338-952D3C49-FEEA-48CB-B149-637EA92A671CQ35832967-541B5226-FBA4-41DA-8121-ADAD72DE8B3FQ35883937-D246A0E1-82A6-4792-9639-42F8800E5067Q35967478-16D8A2C5-C2BE-4AFA-9124-D42842AF3E12Q36207245-E2A2B969-C4FC-4C1E-AB33-29156A9ABE08Q36237555-26C849DA-7CD4-4C45-822A-D2339FE57584Q36269684-B5071C16-055B-4040-8E9A-B1976056FA50Q36359764-DB58057B-B269-4681-A2A7-DAE1B60F7C53Q36661194-831221C0-D551-4859-B971-913A1F342DA8Q36746907-303EEFE3-84CF-48A1-8A6F-F615DC483724Q36927013-D4C18A73-7A0D-446E-8F78-EA9E8034ABD6Q37067749-BD74CF44-DA97-43BA-A584-30627FA3E369Q37082686-E3606AC7-E6B9-4BDD-BA3B-E432ADA85014Q37190302-9F8F7045-5FEF-49BB-A92A-931492535CAFQ37309060-55D63AD0-C49F-457D-AF2B-DFD1A6DEF613Q37321012-88A2CD26-A0F6-4D39-8E01-CF081382F3A3Q37468111-75704732-B709-4191-A973-F479A0DF977EQ37488838-4AFA5F9B-2252-4F4A-99D4-5B2B19047094Q37580677-BA3BCD06-EE8C-4D0D-B8E3-0FD70D039F11Q37984817-4EA7B5C4-C1A4-4E1D-B3F4-8DAB1ABCE78DQ38056849-DAED05DD-C02C-4F3E-BB4C-59BF594CB627Q38260502-E7DE1D71-24E1-42D5-B7C7-282EF29C3668
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatitis B and hepatocellular carcinoma
@ast
Hepatitis B and hepatocellular carcinoma
@en
Hepatitis B and hepatocellular carcinoma
@nl
type
label
Hepatitis B and hepatocellular carcinoma
@ast
Hepatitis B and hepatocellular carcinoma
@en
Hepatitis B and hepatocellular carcinoma
@nl
prefLabel
Hepatitis B and hepatocellular carcinoma
@ast
Hepatitis B and hepatocellular carcinoma
@en
Hepatitis B and hepatocellular carcinoma
@nl
P2860
P356
P1433
P1476
Hepatitis B and hepatocellular carcinoma
@en
P2860
P304
P356
10.1002/HEP.22962
P407
P433
P577
2009-05-01T00:00:00Z